LEADER 02228oam  2200613   450 
001 9910717174403321
005 20220218104250.0
035   $a(CKB)5470000002528470
035   $a(OCoLC)1236944902
035   $a(OCoLC)995470000002528470
035   $a(EXLCZ)995470000002528470
100   $a20210202d2020      ua             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aCOVID-19 $eFederal Efforts Accelerate Vaccine and Therapeutic Development, but More Transparency Needed on Emergency Use Authorizations : report to congressional addressees
210  1$aWashington, DC :$cUnited States Government Accountability Office,$d2020.
215   $a1 online resource (ii, 46 pages) $ccolor illustrations
300   $a"November 2020."
300   $a"GAO-21-207."
320   $aIncludes bibliographical references.
517   $aCOVID-19 
606   $aCOVID-19 (Disease)$xPrevention$xGovernment policy$zUnited States
606   $aCOVID-19 (Disease)$xTreatment$xGovernment policy$zUnited States
606   $aCOVID-19 (Disease)$xResearch$xGovernment policy$zUnited States
606   $aEmergency management$zUnited States
606   $aTransparency in government$zUnited States
606   $aCOVID-19 (Disease)$xPrevention$xGovernment policy$2fast
606   $aEmergency management$2fast
606   $aTransparency in government$2fast
607   $aUnited States$2fast
615  0$aCOVID-19 (Disease)$xPrevention$xGovernment policy
615  0$aCOVID-19 (Disease)$xTreatment$xGovernment policy
615  0$aCOVID-19 (Disease)$xResearch$xGovernment policy
615  0$aEmergency management
615  0$aTransparency in government
615  7$aCOVID-19 (Disease)$xPrevention$xGovernment policy.
615  7$aEmergency management.
615  7$aTransparency in government.
702   $aDenigan-Macauley$b Mary
702   $aHundrup$b Alyssa M.
801  0$bLVT
801  1$bLVT
801  2$bDID
801  2$bOCLCF
801  2$bGPO
801  2$bOCLCO
801  2$bGPO
906   $aBOOK
912   $a9910717174403321
996   $aCOVID-19$92802534
997   $aUNINA